Conditions: Inflammation Pain Cataract
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 256
Healthy volunteers: no

Brief summary:
The primary objective of this study is to assess the efficacy and safety of 2 concentrations of RX-10045 ophthalmic solution, 0.05% and 0.1%, compared to placebo for the treatment of ocular inflammation and pain in subjects undergoing cataract surgery.

Detailed description:

Arms:
arm 1: topical eye drops arm 2: topical eye drops arm 3: topical eye drops

Interventions: intervention 1: RX-10045
Intervention descriptions: intervention 1: topical therapy

Protocol document: